Erschienen in:
01.06.2012 | Image of the Month
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
verfasst von:
A. Afshar-Oromieh, U. Haberkorn, M. Eder, M. Eisenhut, CM. Zechmann
Erschienen in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Ausgabe 6/2012
Einloggen, um Zugang zu erhalten
Excerpt
Prostate-specific membrane antigen (PSMA) is a cell surface protein, which is expressed at higher levels in prostate cancer compared to other tissues. This protein provides a promising target for specific imaging and therapy due to its transmembrane location and internalization after ligand binding [
1]. PSMA is also expressed in the neovasculature of many solid tumours [
2,
3]. Recently procedures have been developed to label PSMA with
68Ga and
124I for positron emission tomography (PET) imaging [
4,
5]. …